In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 ...
Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When ...
A recent study by UW researchers found that the 2019 “Hep C Free Washington” initiative was correlated with a decrease in the ...
Veteran pharma leader and infectious disease pioneer joins QBI to accelerate translation of world-class PPI science into industry partnerships and therapeutic impact–SAN FRANCISCO--(BUSINESS ...
SHELTON, CT / ACCESS Newswire / May 11, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the ...
The podcast host and Fox News contributor has criticized parts of the Trump administration while aligning with many MAHA priorities ...
Diwan, PhD, President and Executive Chairman of the Company, adding, "Physicians in charge could have sought it under ...
The developments come as the Trump administration sees a marked rise in the influence of anti-vaccine figures and movements, ...
Kennedy touts MAHA. This Mother's Day, note what his misinformation and policies really do to moms: reduce access to care, ...
Police arrested 4 men who diverted the medicines, tampered with their packaging, and resold them illegally across Delhi-NCR ...
In a Truth Social post announcing his next surgeon general nominee, President Donald Trump praised Dr. Nicole Saphier as "an INCREDIBLE communicator" who breaks down complex health issues for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results